Natalizumab News

← Back to News Overview


Natalizumab currently has 13 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Natalizumab with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
  • Original indication: Tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (RRMS) for the following patient groups: Patients with highly active...
  • Evidence level: L5
  • Predicted indications (20):
    • bronchitis (99.5%)
    • parapsoriasis (99.4%)
    • psoriasis (99.2%)
    • severe nonproliferative diabetic retinopathy (99.2%)
    • acute lichenoid pityriasis (99.0%)
    • pityriasis lichenoides (98.7%)
    • penile fibromatosis (98.4%)
    • pustulosis palmaris et plantaris (98.3%)
    • dermatitis (98.2%)
    • neonatal dermatomyositis (97.7%)
    • palmar fibromatosis (97.7%)
    • Ledderhose disease (97.7%)
    • acrodermatitis chronica atrophicans (97.7%)
    • secondary interstitial lung disease specific to childhood associated with a connective tissue disease (97.6%)
    • amyopathic dermatomyositis (97.6%)
    • acne keloid (97.6%)
    • infantile digital fibromatosis (97.6%)
    • psoriasis 14, pustular (97.6%)
    • hydroa vacciniforme, familial (97.2%)
    • inflammatory bowel disease (97.0%)

View full drug report →

Imidazolpropionat aus dem Darm: möglicher Verstärker der Alzheimer-Pathologie - it boltwise

2026-10-11 diabetes MS

Source: it boltwise


«Diabete dopo il Covid?»: scoperto come il virus sabota la produzione di insulina

2026-10-11 diabete

Source: Mondosanità


Foundayo: Orforglipron senkt das vorhergesagte Diabetesrisiko um bis zu 57 Prozent

2026-10-11 diabetes

Source: ad-hoc-news.de


PCOS auch bei Normalgewicht: Meta-Analyse zeigt deutlich erhöhte Stoffwechselrisiken - it boltwise

2026-10-11 diabetes

Source: it boltwise


Diabete, scoperto un «interruttore» che danneggia il filtro dei reni: ecco come agisce

2026-10-10 diabete

Source: Mondosanità


Retatrutide bei Diabetes: 52 Prozent verlieren mindestens 20 Prozent Gewicht - AD HOC NEWS

2026-10-10 diabetes MS

Source: AD HOC NEWS


Vous êtes fatigué en ce début d’automne ? C’est normal mais vous pouvez y remédier - Le HuffPost

2026-10-10 EPOC

Source: Le HuffPost


Typ-2-Diabetes bei 20- bis 45-Jährigen: Armut erhöht das Erkrankungsrisiko

2026-10-09 diabetes

Source: ad-hoc-news.de


Du canal carpien à l’épaule gelée : l’autre fardeau du diabète

2026-10-09 diabète

Source: Medscape


Normoglykämisch – trotzdem Diabetes-gefährdet?

2026-10-08 diabetes

Source: AerzteZeitung.de


The generation raised on sugar rations – and what their health reveals 70 years later - The Guardian

2026-10-07 diabetes high blood pressure

Source: The Guardian


Früherkennung und Ketoazidose: Abbott Big City Talk in Berlin - Monitor Versorgungsforschung

2026-10-07 Metformin diabetes

Source: Monitor Versorgungsforschung


Santé. Diabète de type 5 : c’est quoi cette maladie qui pourrait concerner des millions de personnes ? - Le Progrès

2026-10-06 diabète

Source: Le Progrès


Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.

Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.